CStone Pharmaceuticals Statistics

Total Valuation

HKG:2616 has a market cap or net worth of HKD 13.01 billion. The enterprise value is 12.68 billion.

Market Cap	13.01B
Enterprise Value	12.68B

Important Dates

The next estimated earnings date is Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2616 has 1.46 billion shares outstanding. The number of shares has increased by 1.04% in one year.

Current Share Class	1.46B
Shares Outstanding	1.46B
Shares Change (YoY)	+1.04%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	1.50%
Owned by Institutions (%)	11.95%
Float	1.03B

Valuation Ratios

PE Ratio	n/a
Forward PE	33.31
PS Ratio	58.62
PB Ratio	37.68
P/TBV Ratio	74.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-30.69
EV / Sales	57.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 1.24.

Current Ratio	1.44
Quick Ratio	1.20
Debt / Equity	1.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.86

Financial Efficiency

Return on equity (ROE) is -96.36% and return on invested capital (ROIC) is -30.55%.

Return on Equity (ROE)	-96.36%
Return on Assets (ROA)	-16.92%
Return on Invested Capital (ROIC)	-30.55%
Return on Capital Employed (ROCE)	-65.13%
Revenue Per Employee	2.39M
Profits Per Employee	-4.44M
Employee Count	135
Asset Turnover	0.15
Inventory Turnover	1.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +567.42% in the last 52 weeks. The beta is 0.04, so HKG:2616's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	+567.42%
50-Day Moving Average	5.86
200-Day Moving Average	3.51
Relative Strength Index (RSI)	69.96
Average Volume (20 Days)	23,097,416

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2616 had revenue of HKD 221.89 million and -413.21 million in losses. Loss per share was -0.32.

Revenue	221.89M
Gross Profit	-27.03M
Operating Income	-404.03M
Pretax Income	-413.21M
Net Income	-413.21M
EBITDA	-389.71M
EBIT	-404.03M
Loss Per Share	-0.32

Full Income Statement

Balance Sheet

The company has 756.20 million in cash and 428.86 million in debt, giving a net cash position of 327.34 million or 0.22 per share.

Cash & Cash Equivalents	756.20M
Total Debt	428.86M
Net Cash	327.34M
Net Cash Per Share	0.22
Equity (Book Value)	345.22M
Book Value Per Share	0.26
Working Capital	302.10M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -12.18%, with operating and profit margins of -182.09% and -186.23%.

Gross Margin	-12.18%
Operating Margin	-182.09%
Pretax Margin	-186.23%
Profit Margin	-186.23%
EBITDA Margin	-175.64%
EBIT Margin	-182.09%
FCF Margin	n/a

Dividends & Yields

HKG:2616 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.04%
Shareholder Yield	n/a
Earnings Yield	-3.18%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a